Brief: First Wave BioPharma Enters into Term Sheet for Business Combination with ImmunogenX

GridAI Technologies

18/12/2023 11:17

Dec 18 (Reuters) - First Wave BioPharma Inc  FWBI.O :
    * FIRST WAVE BIOPHARMA ANNOUNCES ENTRY INTO TERM SHEET FOR
BUSINESS COMBINATION WITH IMMUNOGENX ESTABLISHING A LEADING
LATE-STAGE GI-FOCUSED BIOPHARMACEUTICAL COMPANY
    * FIRST WAVE BIOPHARMA INC: PURSUANT TO TERM SHEET, FIRST
WAVE
BIOPHARMA WILL ACQUIRE IMMUNOGENX IN AN ALL-STOCK TRANSACTION
    * FIRST WAVE BIOPHARMA INC: FOLLOWING CONSUMMATION OF
TRANSACTION,
FIRST WAVE BIOPHARMA WILL CONTINUE TO TRADE ON NASDAQ UNDER
TICKER SYMBOL "FWBI"

Source text for Eikon:  ID:nGNX9QL1Gf 
Further company coverage:  FWBI.O 

 ((Reuters.Briefs@thomsonreuters.com;))